Clinical manifestations and treatment outcome of thyrotoxic periodic paralysis
Phase 4
Completed
- Conditions
- Thyrotoxic periodic paralysis
- Registration Number
- TCTR20180129001
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
The patients were 15 years of age or older who presented with hypokalemia (serum K+ concentration < 3.0 mmol/l) and acute muscle weakness with thyrotoxicosis.
Exclusion Criteria
Patients with history of diuretics used, diarrhea or other underlying disease that could caused muscle weakness were excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical features, laboratory test, treatments and outcome of treatment in Thai TPP patients. During TPP attack and after TPP treatment physical and neurological examination, blood chemistry when TPP was diagnosed and after treatment,
- Secondary Outcome Measures
Name Time Method Hemodynamic (mean arterial pressure and heart rate) changes During surgery standard monitoring (Blood pressure (BP), Pulse rate (PR), Electrocardiography (ECG), end tidal carb